Management of asthma in pregnancy
- PMID: 39701495
- PMCID: PMC11773012
- DOI: 10.1016/j.clinme.2024.100277
Management of asthma in pregnancy
Abstract
Asthma is the most common chronic disease to affect pregnant women and can have a significant effect on pregnancy outcomes, with increased rates of preterm birth, premature delivery and caesarean section observed if poorly controlled. Pregnancy can also influence asthma control. Prescribing in pregnancy causes anxiety for patients and healthcare professionals and can result in alteration or undertreatment of asthma. Good asthma control with prompt and adequate management of exacerbations is key to reducing adverse pregnancy outcomes for both mother and fetus. The majority of asthma treatment can be continued as normal in pregnancy and there is emerging evidence of the safety of biologic medications also. This article aims to summarise the current evidence about asthma in pregnancy and guide the appropriate management of this population.
Keywords: Asthma; Biologics for asthma; Biologics in pregnancy; Maternal medicine; Pregnancy; Prescribing in pregnancy.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- NICE Clinical Knowledge summary: asthma. Updated 2024. https://cks.nice.org.uk/topics/asthma/. Accessed 29 November, 2024.
-
- Global Initiative for Asthma (GINA). Global strategy of asthma management and prevention. 2024. Available from https://ginasthma.org. Accessed 23 November, 2024.
-
- Forbes RL, Gibson PG, Murphy VE, et al. Impaired type I and II interferon response to rhinovirus infection during pregnancy and asthma. Thorax. 2021;67(3):209–214. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
